High-sensitivity cardiac troponin T in geriatric inpatients

Shao-Jing Zhang1, Qing Wang1, Yun-Jing Cui1

  • 1Department of Geriatrics, Fuxing Hospital Affiliated to Capital Medical University, Beijing, China.

Insights

High-sensitivity cardiac troponin T (hs-cTnT) is commonly detected in elderly patients, even without cardiovascular disease. Elevated hs-cTnT levels are linked to increased cardiovascular risks and are influenced by factors like age and kidney function.

Area of Science:

  • Cardiology
  • Geriatrics
  • Biomarkers

Background:

  • High-sensitivity cardiac troponin T (hs-cTnT) is frequently detectable in elderly individuals without diagnosed cardiovascular disease.
  • Elevated hs-cTnT levels in this population are associated with heightened cardiovascular risks and poorer prognosis.

Purpose of the Study:

  • To investigate the distribution of hs-cTnT levels in geriatric inpatients without acute coronary syndrome (ACS).
  • To identify factors associated with hs-cTnT levels in this specific patient group.

Main Methods:

  • Hs-cTnT was measured using a sensitive assay in 679 geriatric inpatients without ACS.
  • Patients were stratified into tertiles based on hs-cTnT levels.
  • Univariable and multivariable analyses assessed associations with cardiovascular risk factors, biochemical markers, and echocardiographic findings.

Main Results:

  • Hs-cTnT was detectable (≥3 ng/L) in 98.4% of subjects; 52.0% had levels ≥14 ng/L (99th percentile URL).
  • Independent predictors of hs-cTnT included NT-proBNP, male gender, older age, eGFR, LVMI, DM, and LVEF.
  • No significant difference in hs-cTnT levels was observed between patients with and without stable coronary artery disease (SCAD).

Conclusions:

  • Elevated hs-cTnT due to non-ischemic causes is common in hospitalized elderly patients.
  • Assessing hs-cTnT level changes (rise/fall) is crucial for diagnosing ACS/AMI in the elderly, considering elevated baseline levels.
  • Further research is needed to establish age-specific 99th percentile values for hs-cTnT in the elderly.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
411
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
311
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
330
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
345
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
314